C. Michael Gibson
Boston Biomedical Research Institute(US)Beth Israel Deaconess Medical Center(US)Harvard University(US)Wellesley College(US)St. Mary Medical Center(US)Angelo State University(US)Methodist Hospital(US)St. Antonius Ziekenhuis(NL)Baim Institute for Clinical Research(US)Institute of Clinical Research(US)CytoSorbents (United States)(US)EVERSANA (Canada)(CA)
Publications by Year
Research Areas
Acute Myocardial Infarction Research, Coronary Interventions and Diagnostics, Antiplatelet Therapy and Cardiovascular Diseases, Cardiac Imaging and Diagnostics, Atrial Fibrillation Management and Outcomes
Most-Cited Works
- → Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes(2007)6,705 cited
- → COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up(2020)2,917 cited
- → Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation(2005)1,915 cited
- → Rivaroxaban in Patients with a Recent Acute Coronary Syndrome(2011)1,878 cited
- → Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI(2016)1,535 cited
- → Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial(2009)1,056 cited